Off-Label Dosing of Direct Oral Anticoagulants: Prescribing Error or Opportunity in Treating Patients with Atrial Fibrillation?

被引：1
|
作者：
Poli, Daniela [1 ]
机构：
[1] Azienda Osped Univ Careggi, Thrombosis Ctr, Dept Crit Care Med, Viale Morgagni 85, I-40134 Florence, Italy
来源：
THROMBOSIS AND HAEMOSTASIS | 2025年 / 125卷 / 03期
关键词：
EXTENDED TREATMENT; MANAGEMENT; THERAPY;
D O I：
10.1055/a-2441-8902
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：286 / 289
页数：4
相关论文
共 50 条
  • [41] Dosing of Direct Oral Anticoagulants in Patients With Non-Valvular Atrial Fibrillation and Renal Dysfunction
    Rymer, Jennifer A.
    Webb, Laura E.
    Wang, Tracy Y.
    CIRCULATION, 2021, 144
  • [42] Comparison of Renal Function Estimation Formulae for Dosing Direct Oral Anticoagulants in Patients with Atrial Fibrillation
    Lee, Kwang-No
    Choi, Jong-Il
    Kim, Yun Gi
    Boo, Ki Yung
    Kim, Do Young
    Choi, Yun Young
    Choi, Ha Young
    Kim, Dong-Hyeok
    Lee, Dae In
    Roh, Seung-Young
    Shim, Jaemin
    Kim, Jin Seok
    Kim, Young-Hoon
    JOURNAL OF CLINICAL MEDICINE, 2019, 8 (12)
  • [43] Differences in Preferences Between Physicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation
    Rymer, Jennifer A.
    McCall, Debbe
    Hills, Mellanie T.
    Wang, Tracy Y.
    CIRCULATION, 2020, 142
  • [44] Inappropriate dosing of direct oral anticoagulants in patients with atrial fibrillation undergoing percutaneous coronary intervention
    Kitahara, H.
    Tanabe, Y.
    Yamazaki, T.
    Hiraga, T.
    Abe, K.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [45] Differences in Preferences Between Clinicians and Patients for the Use and Dosing of Direct Oral Anticoagulants for Atrial Fibrillation
    Rymer, Jennifer A.
    Webb, Laura
    McCall, Debbe
    Hills, Mellanie T.
    Wang, Tracy Y.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (11):
  • [46] Prescribing of two potentially interacting cardiovascular medications in atrial fibrillation patients on direct oral anticoagulants
    Shurrab, Mohammed
    Koh, Maria
    Jackevicius, Cynthia A.
    Qiu, Feng
    Conlon, Michael
    Caswell, Joseph
    Tu, Karen
    Austin, Peter C.
    Ko, Dennis T.
    IJC HEART & VASCULATURE, 2021, 34
  • [47] Direct oral anticoagulants (DOACs) for off-label use in patients with Budd Chiari Syndrome (BCS)
    Semmler, Georg
    Pomej, Katharina
    Bauer, David J. M.
    Balcar, Lorenz
    Hofer, Benedikt S.
    Simbrunner, Benedikt
    Pinter, Matthias
    Trauner, Michael
    Mandorfer, Mattias
    Reiberger, Thomas
    Scheiner, Bernhard
    JOURNAL OF HEPATOLOGY, 2021, 75 : S681 - S681
  • [48] Safety of off-label dose reduction of non-vitamin K oral anticoagulants in patients with atrial fibrillation treated in routine care
    van den Dries, Carline
    van den Ham, Rianne
    Souverein, Patrick
    Pjouheshnia, Romin
    Geersing, Geert-Jan
    van Doorn, Sander
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 140 - 141
  • [49] Direct Oral Anticoagulants in Atrial Fibrillation
    Noll, Georg
    Noll, Sarah
    Huerlimann, David
    SEMINARS IN HEMATOLOGY, 2014, 51 (02) : 139 - 146
  • [50] Prescribing patterns of direct oral anticoagulants for atrial fibrillation in a tertiary military hospital
    Gill, M. Singh
    Rus, M. R. Mohamed
    Hussin, F. R.
    Kassim, N. Mohd
    Zulkufli, M. R.
    Zin, Z. F.
    Rawi, S. R. Mohd
    Ayob, A.
    Kamal, M. Y. Mohd
    Alias, J.
    Zulkifly, N.
    Subhi, A. M. S. Abang Mohd
    Afandi, N. A. Arif
    Anumathan, S.
    Yusop, F.
    Yusof, S. Mohd
    Ani, C. E.
    Rani, N. H.
    Senin, N. A.
    Razak, M. Abdul
    Rosri, M. N.
    Yatim, A. Md
    Hassan, N. H.
    Ringo, K.
    Rena, M.
    Khalid, K. A. Abdul
    Khalid, K. A. Abdul
    Zawawi, M. F. Ahmad
    Aziz, Z.
    Shahril, N. S.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2021, 345 : 23 - 23
12345